1/58
A comprehensive vocabulary review of Chapter 14: Blood, covering blood composition, formed elements, hematopoiesis, red blood cell life cycle and anemias, leukocyte types and functions, plasma proteins and electrolytes, hemostasis, blood clotting cascades, and ABO/Rh transfusion compatibility.
Blood
The only type of connective tissue with a liquid extracellular matrix (plasma) that transports vital substances, distributes heat, and helps maintain interstitial fluid stability and homeostasis; has a normal pH of 7.3–7.5, makes up about 8% of body weight, and has a volume of 4 to 5liters in females and 5 to 6liters in males.
Formed elements
The cellular portion of blood that forms mostly in red bone marrow, comprising red blood cells (95.1% of formed elements), platelets (4.8%), and white blood cells (0.1%), accounting for about 45% of total blood volume.
Plasma
The clear, straw-colored liquid matrix found at the top of a centrifuged blood sample, making up approximately 55% of blood volume; composed of 92% water, 7% proteins, as well as electrolytes, wastes, nutrients, vitamins, hormones, and gases.
Hematocrit (HCT)
The percentage of red blood cells in a centrifuged blood sample, normally ranging between 35 to 46% in adult females and 40 to 54% in adult males.
Buffy coat
The thin layer found in the middle of a centrifuged blood tube between the plasma and red blood cells, composed of white blood cells and platelets and accounting for less than 1% of total blood volume.
Universal Precautions
A set of specific safety measures (including PPE, fume hoods, sharps containers, and hand-washing) taken by healthcare workers assuming all patients may have been exposed to bloodborne pathogens like HIV, HBV, and HCV to prevent transmission.
Hematopoiesis
The process of blood cell formation that takes place in red bone marrow from hematopoietic stem cells (hemocytoblasts).
Hematopoietic stem cells (hemocytoblasts)
Stem cells located in red bone marrow that give rise to both lymphoid stem cells and myeloid stem cells, eventually producing all the formed elements of blood.
Erythrocyte
A biconcave disc-shaped red blood cell measuring 7.5μm in diameter and 2.0μm in thickness; lacks nuclei and mitochondria, produces ATP through glycolysis, and consists of about one-third hemoglobin to transport oxygen and carbon dioxide.
Oxyhemoglobin
A hemoglobin molecule combined with oxygen, giving blood a bright red color.
Deoxyhemoglobin
A hemoglobin molecule that has released its oxygen, giving blood a darker, bluish-red hue.
Erythropoiesis
The production of red blood cells in red bone marrow, regulated by a negative feedback mechanism and stimulated by the hormone erythropoietin.
Erythropoietin (EPO)
A hormone secreted by the kidneys and liver in response to low blood oxygen levels that stimulates red bone marrow to accelerate red blood cell production.
Intrinsic factor
A substance secreted by the stomach that is required for the absorption of vitamin B12 in the small intestine, essential for red blood cell DNA synthesis.
Pernicious anemia
A type of anemia resulting from a deficiency of intrinsic factor from the stomach, which leads to inadequate absorption of vitamin B12 and impaired DNA synthesis.
Aplastic anemia
A form of anemia caused by the destruction of red bone marrow by radiation, certain medications, cancer, viruses, or certain poisons, resulting in a decreased RBC count.
Hemolytic anemia
A condition characterized by a reduced RBC count caused by the premature destruction of red blood cells due to bacterial infections or blood transfusion incompatibilities.

Sickle cell anemia
A genetic condition caused by an abnormal gene that produces an abnormal hemoglobin structure, causing red blood cells to bend into rigid, sickle-like crescent shapes that can obstruct capillaries.
Thalassemia
An inherited anemia caused by a defective gene resulting in deficient hemoglobin synthesis and abnormally short-lived red blood cells.
Transferrin
A transport protein in blood plasma that carries iron released from decomposing hemoglobin to the red bone marrow for reuse.
Ferritin
An iron-protein complex in which excess iron from broken-down red blood cells is stored within the liver.
Biliverdin
A greenish pigment produced when the heme group of hemoglobin is broken down during red blood cell destruction by macrophages in the spleen and liver.
Bilirubin
An orange-yellow pigment converted from biliverdin that is excreted into bile by the liver or eliminated by the kidneys in urine as derivatives.

Diapedesis
The migration process in which white blood cells squeeze between the endothelial cells lining capillary walls to enter surrounding connective tissues and migrate to sites of injury or infection.
Positive chemotaxis
The directional attraction and movement of white blood cells toward an infection or injury site in response to chemicals released by damaged cells.

Neutrophil
A granulocyte characterized by fine cytoplasmic granules that stain light purple in acid-base stain and a nucleus with 2 to 5 lobes; makes up 50 to 70% of leukocytes, responds first to infections, and actively phagocytizes small particles.

Eosinophil
A granulocyte featuring coarse cytoplasmic granules that stain deep red in acid stain and a bilobed nucleus; makes up 1 to 3% (1 to 4%) of leukocytes, kills parasitic worms, and moderates allergic reactions.

Basophil
A granulocyte containing large, coarse granules that stain deep blue in basic stain and often obscure its lobed nucleus; accounts for less than 1% of leukocytes and releases histamine to promote inflammation and heparin to inhibit blood clotting.

Monocyte
The largest type of white blood cell, an agranulocyte with a kidney-shaped, oval, or lobed nucleus that makes up 3 to 9% of leukocytes; leaves the bloodstream to become a tissue macrophage that phagocytizes large particles, dead cells, and debris.

Lymphocyte
The smallest white blood cell, an agranulocyte containing a large spherical nucleus surrounded by a thin rim of cytoplasm; makes up 25 to 33% of circulating leukocytes and includes T cells (directly attack pathogens) and B cells (produce antibodies).
Leukocytosis
An abnormally high white blood cell count exceeding 10,500/μL, commonly indicating acute bacterial infections, vigorous exercise, or severe loss of body fluids.
Leukopenia
An abnormally low white blood cell count falling below 3,500/μL, associated with conditions such as typhoid fever, influenza, measles, mumps, chicken pox, AIDS, polio, and anemia.
Differential WBC count
A diagnostic procedure that lists the percentages of each type of white blood cell in a sample to help identify specific infections or disorders.
Platelet (thrombocyte)
A small, enucleated cytoplasmic fragment measuring less than half the size of a red blood cell, produced by megakaryocytes in response to thrombopoietin; normal count is 150,000 to 400,000/μL, and it functions in hemostasis by sticking to broken vessel surfaces and releasing serotonin.
Albumins
The most abundant plasma proteins (60% of total), synthesized by the liver, that play a key role in maintaining the colloid osmotic pressure of blood.
Alpha and beta globulins
Plasma proteins synthesized by the liver that make up a subcategory of globulins and function in transporting lipids and fat-soluble vitamins.
Gamma globulins
A class of plasma globulins produced by lymphatic tissues (plasma cells) that constitute circulating antibodies providing immunity.
Fibrinogen
A large soluble plasma protein (4% of total plasma proteins) synthesized in the liver that is converted to insoluble fibrin threads during blood coagulation.
Nonprotein Nitrogenous Substances (NPNs)
Molecules that contain nitrogen but are not proteins, including urea (∼50% of NPNs), uric acid, amino acids, creatine, and creatinine.
Blood urea nitrogen (BUN)
A laboratory test measuring urea concentration in the blood, where an elevated level indicates impaired renal function and failure of the kidneys to excrete urea properly.
Hemostasis
The physiological process that halts bleeding from a broken vessel, consisting of vascular spasm, platelet plug formation, and blood coagulation.
Vascular spasm
The rapid, reflexive contraction of vascular smooth muscle stimulated by direct wall injury or pain receptors, prolonged by serotonin released from platelets to restrict blood loss.
Platelet plug
A physical barrier formed when platelets adhere to exposed collagen and rough surfaces of an injured blood vessel, and subsequently adhere to each other to help prevent blood escape.
Extrinsic clotting mechanism
A rapid blood coagulation pathway triggered when blood contacts damaged blood vessel walls or tissues outside vessels, initiated by the release of tissue thromboplastin (factor III).
Intrinsic clotting mechanism
A blood coagulation pathway that can initiate without tissue damage when blood contacts a foreign surface or collagen within a broken vessel, initiated by Hageman factor XII.
Prothrombin activator
An enzymatic complex generated by clotting factor cascades that, in the presence of calcium ions (Ca+2), converts prothrombin (factor II) into active thrombin.
Thrombin
An active enzyme converted from prothrombin that cleaves soluble fibrinogen molecules into fragments, which then join to form insoluble strands of fibrin.
Fibrin
An insoluble, thread-like mesh of protein polymers converted from fibrinogen by thrombin that traps blood cells and platelets to form a stable blood clot.
Serum
The pale yellowish fluid that is squeezed out of a retracting blood clot, consisting of plasma minus fibrinogen and most clotting factors.
Plasmin
A fibrin-digesting enzyme that dissolves the insoluble fibrin threads of a blood clot after tissue repair is underway.
Thrombus
An abnormal, stationary blood clot formed inside an unbroken or damaged blood vessel.
Embolus
A thrombus or fragment of an abnormal blood clot that breaks loose and travels through the bloodstream.

Atherosclerosis
The accumulation of fatty deposits (plaque) along arterial linings, which narrows the lumen and creates a rough surface that can stimulate abnormal thrombus formation.
Prostacyclin (PGI2)
A prostaglandin synthesized and released by healthy vascular endothelial cells that prevents platelets from adhering to intact blood vessel walls.
Antithrombin
A circulating anticoagulant protein that binds directly to thrombin, inactivating it and preventing the clotting cascade from spreading beyond the injury site.
Agglutination
The clumping of red blood cells that occurs when specific plasma antibodies encounter and cross-link corresponding surface antigens on incompatible donor red blood cells.
Universal donor
An individual with blood type O (specifically O-), whose red blood cells lack both antigen A and antigen B, preventing agglutination when transfused into recipients with anti-A or anti-B antibodies.
Universal recipient
An individual with blood type AB (specifically AB+), whose plasma lacks both anti-A and anti-B antibodies, allowing them to receive red blood cells of any ABO blood type.
Erythroblastosis fetalis
A life-threatening hemolytic disease of the newborn occurring when an Rh-negative mother, previously sensitized to Rh antigen D during an earlier pregnancy or transfusion, produces anti-Rh antibodies that cross the placenta to attack the red blood cells of an Rh-positive fetus.